Clinical Trial Update: Letrozole or Tamoxifen in Treating Postmenopausal Women With Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial comparing letrozole versus tamoxifen in postmenopausal women with breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• FEMARA (letrozole)
• Nolvadex (tamoxifen)

Snippet

Sponsor: ETOP IBCSG Partners Foundation | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED